Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Detection of antineutrophil cytoplasmic antibodies (ANCAs): a multicentre European Vasculitis Study Group (EUVAS) evaluation of the value of indirect immunofluorescence (IIF) versus antigen-specific immunoassays

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Use of composite outcomes facilitate core outcome set uptake in rheumatoid arthritis trials

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Cold-Steel Phonosurgery of Reinke Edema Evaluated by the Multidimensional Voice Program

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Individual values of antineutrophil cytoplasmic antibodies do not correspond between antigen-specific assays

    Research output: Contribution to journalLetterResearchpeer-review

  3. Vaskulit

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearchpeer-review

  4. Assessment of Disease Activity in Large-vessel Vasculitis: Results of an International Delphi Exercise

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Jan Damoiseaux
  • Elena Csernok
  • Niels Rasmussen
  • Frank Moosig
  • Pieter van Paassen
  • Bo Baslund
  • Pieter Vermeersch
  • Daniel Blockmans
  • Jan-Willem Cohen Tervaert
  • Xavier Bossuyt
View graph of relations

OBJECTIVE: This multicentre study was performed to evaluate the diagnostic accuracy of a wide spectrum of novel technologies nowadays available for detection of myeloperoxidase (MPO) and proteinase 3 (PR3)-antineutrophil cytoplasmic antibodies (ANCAs).

METHODS: Sera (obtained at the time of diagnosis) from 251 patients with ANCA-associated vasculitis (AAV), including granulomatosis with polyangiitis and microscopic polyangiitis, and from 924 disease controls were tested for the presence of cytoplasmic pattern/perinuclear pattern and atypical ANCA (A-ANCA) by indirect immunofluorescence (IIF) (at two sites) and for the presence of PR3-ANCA and MPO-ANCA by eight different immunoassays.

RESULTS: The area under the curve (AUC) of the receiver operating characteristic curve to discriminate AAV from controls was 0.923 (95% CI 0.902 to 0.944) and 0.843 (95% CI 0.814 to 0.871) for the two IIF methods. For the antigen-specific immunoassays, the AUC varied between 0.936 (95% CI 0.912 to 0.960) and 0.959 (95% CI 0.941 to 0.976), except for one immunoassay for which the AUC was 0.919 (95% CI 0.892 to 0.945).

CONCLUSIONS: Our comparison of various ANCA detection methods showed (i) large variability between the two IIF methods tested and (ii) a high diagnostic performance of PR3-ANCA and MPO-ANCA by immunoassay to discriminate AAV from disease controls. Consequently, dual IIF/antigen-specific immunoassay testing of each sample is not necessary for maximal diagnostic accuracy. These results indicate that the current international consensus on ANCA testing for AAV needs revision.

Original languageEnglish
JournalAnnals of the Rheumatic Diseases
Volume76
Issue number4
Pages (from-to)647-653
Number of pages7
ISSN0003-4967
DOIs
Publication statusPublished - Apr 2017

    Research areas

  • Journal Article

ID: 49913880